Literature DB >> 28355118

Carbonyl Compounds Produced by Vaporizing Cannabis Oil Thinning Agents.

William D Troutt1, Matthew D DiDonato1.   

Abstract

OBJECTIVE: Cannabis use has increased in the United States, particularly the use of vaporized cannabis oil, which is often mixed with thinning agents for use in vaporizing devices. E-cigarette research shows that heated thinning agents produce potentially harmful carbonyls; however, similar studies have not been conducted (1) with agents that are commonly used in the cannabis industry and (2) at temperatures that are appropriate for cannabis oil vaporization. The goal of this study was to determine whether thinning agents used in the cannabis industry produce potentially harmful carbonyls when heated to a temperature that is appropriate for cannabis oil vaporization.
DESIGN: Four thinning agents (propylene glycol [PG], vegetable glycerin [VG], polyethylene glycol 400 [PEG 400], and medium chain triglycerides [MCT]) were heated to 230°C and the resulting vapors were tested for acetaldehyde, acrolein, and formaldehyde. Each agent was tested three times. SETTING/LOCATION: Testing was conducted in a smoking laboratory. OUTCOME MEASURES: Carbonyl levels were measured in micrograms per puff block.
RESULTS: Analyses showed that PEG 400 produced significantly higher levels of acetaldehyde and formaldehyde than PG, MCT, and VG. Formaldehyde production was also significantly greater in PG compared with MCT and VG. Acrolein production did not differ significantly across the agents.
CONCLUSIONS: PG and PEG 400 produced high levels of acetaldehyde and formaldehyde when heated to 230°C. Formaldehyde production from PEG 400 isolate was particularly high, with one inhalation accounting for 1.12% of the daily exposure limit, nearly the same exposure as smoking one cigarette. Because PG and PEG 400 are often mixed with cannabis oil, individuals who vaporize cannabis oil products may risk exposure to harmful formaldehyde levels. Although more research is needed, consumers and policy makers should consider these potential health effects before use and when drafting cannabis-related legislation.

Entities:  

Keywords:  cannabis oil; cannabis thinning agents; cannabis vaporization; carbonyl production

Mesh:

Substances:

Year:  2017        PMID: 28355118     DOI: 10.1089/acm.2016.0337

Source DB:  PubMed          Journal:  J Altern Complement Med        ISSN: 1075-5535            Impact factor:   2.579


  10 in total

Review 1.  Interpol review of controlled substances 2016-2019.

Authors:  Nicole S Jones; Jeffrey H Comparin
Journal:  Forensic Sci Int Synerg       Date:  2020-05-24

2.  Demographic and substance use-related differences among high school adolescents who vape cannabis versus use other cannabis modalities.

Authors:  Meghan E Morean; Danielle R Davis; Grace Kong; Krysten W Bold; Deepa R Camenga; Sakinah Suttiratana; Juhan Lee; Lavanya Rajeshkumar; Suchitra Krishnan-Sarin
Journal:  Drug Alcohol Depend       Date:  2021-09-27       Impact factor: 4.492

Review 3.  Toxicology of flavoring- and cannabis-containing e-liquids used in electronic delivery systems.

Authors:  Aleksandr B Stefaniak; Ryan F LeBouf; Anand C Ranpara; Stephen S Leonard
Journal:  Pharmacol Ther       Date:  2021-03-18       Impact factor: 13.400

Review 4.  Use of Medical Cannabis to Treat Traumatic Brain Injury.

Authors:  Danielle C Hergert; Cidney Robertson-Benta; Veronik Sicard; Daniela Schwotzer; Kent Hutchison; Dan P Covey; Davin K Quinn; Joseph R Sadek; Jacob McDonald; Andrew R Mayer
Journal:  J Neurotrauma       Date:  2021-01-25       Impact factor: 4.869

Review 5.  Inhalation Toxicology of Vaping Products and Implications for Pulmonary Health.

Authors:  Hussein Traboulsi; Mathew Cherian; Mira Abou Rjeili; Matthew Preteroti; Jean Bourbeau; Benjamin M Smith; David H Eidelman; Carolyn J Baglole
Journal:  Int J Mol Sci       Date:  2020-05-15       Impact factor: 5.923

6.  The pharmacokinetics, efficacy, and safety of a novel selective-dose cannabis inhaler in patients with chronic pain: A randomized, double-blinded, placebo-controlled trial.

Authors:  Shlomo Almog; Judith Aharon-Peretz; Simon Vulfsons; Miri Ogintz; Hadas Abalia; Tal Lupo; Yael Hayon; Elon Eisenberg
Journal:  Eur J Pain       Date:  2020-06-12       Impact factor: 3.931

7.  Modeled Respiratory Tract Deposition of Aerosolized Oil Diluents Used in Δ9-THC-Based Electronic Cigarette Liquid Products.

Authors:  Anand Ranpara; Aleksandr B Stefaniak; Kenneth Williams; Elizabeth Fernandez; Ryan F LeBouf
Journal:  Front Public Health       Date:  2021-11-04

8.  Chemical Emissions From Heated Vitamin E Acetate-Insights to Respiratory Risks From Electronic Cigarette Liquid Oil Diluents Used in the Aerosolization of Δ9-THC-Containing Products.

Authors:  Ryan F LeBouf; Anand Ranpara; Jason Ham; Michael Aldridge; Elizabeth Fernandez; Kenneth Williams; Dru A Burns; Aleksandr B Stefaniak
Journal:  Front Public Health       Date:  2022-01-21

9.  High-Performance Liquid Chromatography-Tandem Mass Spectrometry Analysis of Carbonyl Emissions from E-Cigarette, or Vaping, Products.

Authors:  Megan McGuigan; Gala Chapman; Erica Lewis; Clifford H Watson; Benjamin C Blount; Liza Valentin-Blasini
Journal:  ACS Omega       Date:  2022-02-21

10.  Method Validation Approaches for Analysis of Constituents in ENDS.

Authors:  Samantha M Reilly; Tianrong Cheng; Jenna DuMond
Journal:  Tob Regul Sci       Date:  2020-07
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.